Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prediction of Survival in Metastatic Breast Cancer
NCT03958136Active, not recruiting
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Dec 2018
- Primary completion
- Dec 2035
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Institut Cancérologique de l'Ouest. Primary endpoints: Creation of complex prospective clinico-biological database in metastatic breast cancer at 15 years and Overall Survival at 15 years. Started Dec 2018; status: active, not recruiting.
Beyond the preview
Go deeper on NCT03958136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03958136.